Edition:
United Kingdom

miRagen Therapeutics Inc (MGEN.OQ)

MGEN.OQ on NASDAQ Stock Exchange Capital Market

7.32USD
5:00pm BST
Change (% chg)

$0.00 (+0.00%)
Prev Close
$7.32
Open
$7.32
Day's High
$7.45
Day's Low
$7.30
Volume
6,833
Avg. Vol
66,894
52-wk High
$15.79
52-wk Low
$5.01

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Buy -0.29 December 17 Jul 2018

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 3 3 3 4
(2) OUTPERFORM 3 3 3 3
(3) HOLD 0 0 0 0
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 1.50 1.50 1.50 1.43

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Sep-18 3 0.87 1.30 0.50 0.50
Quarter Ending Dec-18 3 1.00 1.20 0.80 0.50
Year Ending Dec-18 4 6.82 8.50 4.80 0.90
Year Ending Dec-19 4 2.25 5.50 0.00 1.85
Earnings (per share)
Quarter Ending Sep-18 4 -0.29 -0.26 -0.30 -0.37
Quarter Ending Dec-18 4 -0.30 -0.26 -0.32 -0.38
Year Ending Dec-18 4 -1.06 -1.00 -1.10 -2.10
Year Ending Dec-19 4 -1.58 -1.15 -2.31 -2.30

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Mar-18 1.17 4.78 3.61 307.84
Quarter Ending Dec-17 1.34 1.19 0.15 11.29
Quarter Ending Sep-17 0.31 1.63 1.33 433.01
Quarter Ending Jun-17 0.50 0.72 0.22 43.60
Quarter Ending Mar-17 1.10 0.46 0.64 58.00

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Sep-18 0.87 0.87 0.87 1.00 0.50
Quarter Ending Dec-18 1.00 1.00 1.00 1.13 0.50
Year Ending Dec-18 6.82 6.82 6.82 6.22 0.90
Year Ending Dec-19 2.25 2.25 2.25 2.64 1.85

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Sep-18 0 0 0 0
Quarter Ending Dec-18 0 0 0 0
Year Ending Dec-18 0 0 0 0
Year Ending Dec-19 0 0 0 0
Earnings